Randomised Controlled Trial Evidence on Medicinal Cannabis for Treatment of Mental Health and Substance Use Disorders: A Scoping Review.
This scoping review synthesizes randomised controlled trial evidence medicinal cannabis for treating mental health and substance use disorders. The review addresses previous limitations in study design and quality. It provides clinicians with a clearer…
Therapeutic Use of Cannabis and Cannabinoids: A Comprehensive Review
This review covers therapeutic cannabinoid applications with a focus on FDA-approved uses. It highlights evidence supporting cannabinoids for nausea, appetite, and seizure disorders. Approximately 27% of adults report medical cannabis use, underscoring…
Innovative CBD Oral Delivery System Using Mucoadhesive Hydrogel Patch
This study explores a novel cbd oral delivery system using a mucoadhesive hydrogel patch with PLGA nanospheres. The system enhances bioavailability and sustained release for oral therapeutic applications. It shows promise for improving periodontal…
Unveiling Neurological Benefits: Hemp Extracts in Neurological Disorders
Neurological disorders such as epilepsy, Alzheimer's disease, Parkinson's disease, and multiple sclerosis present significant global health care challenges. This review highlights hemp extract neurological disorders benefits, focusing on hemp leaf,…
Cannabis Use Disorder and Pancreatic Cancer Risk in Chronic Pancreatitis Patients
Cannabis use disorder research update reveals no significant increase in pancreatic cancer risk among chronic pancreatitis patients. This large multicenter retrospective cohort study provides important insights for clinicians. Understanding cannabis…
Medical Cannabis for Best Supportive Care of Patients Affected by Cancers of the Head and Neck: A Narrative Review.
Medical cannabis supportive care offers promising symptom management for patients with head and neck cancers. This narrative review highlights its role in alleviating pain, nausea, and cachexia. Patients affected by these cancers may benefit from…
Clinical Outcomes and Patient Profiles in the UK Medical Cannabis Registry: A k-Means Clustering Analysis.
This study on clinical outcomes UK medical cannabis registry analyzes patient profiles using k-means clustering. It provides real-world evidence on treatment response patterns over 24 months. The findings highlight distinct patient phenotypes that may…
Medicinal Cannabis Extract NTI164 Modulates Pediatric Neuropsychiatric Pathways
Pediatric cannabis neuropsychiatric research reveals NTI164, a low-THC cannabis extract, modifies epigenetic, ribosomal, and immune pathways in PANS. This study provides early molecular insights into cannabis effects on pediatric neuropsychiatric…
UK Medical Cannabis Registry: Two-Year Clinical Outcomes in Depression
The UK Medical Cannabis Registry depression outcomes provide valuable real-world evidence on cannabis-based medicinal products. This two-year case series tracked clinical improvements in mood and anxiety symptoms. The study highlights sustained benefits…
Cannabis and Nicotine Use Linked to Adverse Surgical and Psychosocial Outcomes
Cannabis perioperative pain complications are increasingly recognized in orthopedic trauma surgery. This study reveals cannabis use independently raises risks of surgical and medical complications. Understanding these complications is vital for patient…